Key result
Undifferentiated anaplastic thyroid carcinomas are associated with higher PRKAR1A expression versus normal and differentiated tumors.
Why the study?
Is the expression of PKA regulatory subunits altered in neoplastic thyroid tissues compared to normal tissues, and does it correlate with clinical phenotype?
Observational (n=63)
No
Is the expression of PKA regulatory subunits altered in neoplastic thyroid tissues compared to normal tissues, and does it correlate with clinical phenotype?
Increased PRKAR1A expression is associated with aggressive and undifferentiated thyroid tumors, suggesting a potential role as a biomarker for tumor aggressiveness.
Answers are grounded in this paper and cite their sources.
PRKAR1A overexpression marks aggressive thyroid cancers; hypothesis-generating for its prognostic value and PKA pathway targeting.
The four regulatory subunits (R1A, R1B, R2A, R2B) of protein kinase A (PKA) are differentially expressed in several cancer cell lines and exert distinct roles in both cell growth and cell differentiation control. Mutations of the PRKAR1A gene have been found in patients with Carney complex and in a minority of sporadic anaplastic thyroid carcinomas. The aim of the study was to retrospectively evaluate the expression of different PKA regulatory subunits in benign and non benign human thyroid tumours and to correlate their expression with clinical phenotype. Immunohistochemistry demonstrated a significant increase in PRKAR2B expression in both differentiated and undifferentiated (anaplastic) thyroid tumors in comparison with normal thyroid tissues. Conversely, a significant increase in PRKAR1A expression was only demonstrated in undifferentiated thyroid carcinomas in comparison with normal thyroid tissue and differentiated thyroid tumors. In thyroid cancers without lymph nodal metastases PRKAR1A expression was higher in tumours of more than 2 cm in size (T2 and T3) compared to smaller ones (T1). In conclusion, our data shows that an increased PRKAR1A expression is associated with aggressive and undifferentiated thyroid tumors.
No takes yet. Share an insight, caveat, or question.
Ferrero et al. (2015) conducted an observational in Thyroid tumors (n=63). Thyroid tumor histotype vs. Normal thyroid tissue and benign tumors was evaluated on PRKAR1A immunohistochemistry score (p=<0.0001). PRKAR1A expression was significantly increased in undifferentiated anaplastic thyroid carcinomas (mean IHC score 8.3) compared to normal thyroid tissue and differentiated thyroid tumors.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: